What We Treat
Lahey Hospital & Medical Center’s Institute of Urology treats prostate cancer, bladder cancer, kidney cancer, adrenal cancer, testicular cancer, penile cancer and urethral cancer . Our expert urologists provide the highest level of care possible, delivered with a personalized and compassionate approach.
Men diagnosed with prostate cancer have multiple treatment options at Lahey. For those undergoing surgery, we offer a highly experienced team of surgeons who can perform either robotic or open surgery depending on each individual’s needs.
Our advanced prostate cancer program (for patients with cancer recurrence or metastatic disease), headed by Robert Myers, MD, frequently involves multispecialty care provided the medical oncologists and radiation oncologists at Lahey’s Sophia Gordon Cancer Center.
Manuel Merino, MD, and Daneil Kuftinec, MD, are leading our effort in using MRI to perform a targeted prostate biopsy. In collaboration with the Radiology Department, we offer this exciting technology to men at a high risk for prostate cancer, and particularly those who have undergone a conventional biopsy and are looking for greater accuracy in detecting a potential prostate cancer.
We offer state-of-the-art surgical care for patients with bladder cancer, including both open and robotic radical cystectomy with urinary diversion. If needed, we offer the full spectrum of urinary tract surgical reconstruction including:
- Continent orthotopic neobladder
- Continent catheterizable urinary reservoir
- Ileal conduit/urostomy
Patients with bladder cancer may be eligible for a bladder-sparing approach for treatment. Our highly experienced staff is available at multiple sites to provide treatment. We offer current standard intravesical therapies including Bacillus Calmette-Guerin therapy (BCG) as well as immunotherapy and intravesical chemotherapeutic agents.
When necessary in select cases, we offer upper tract instillation treatment as a technique to treat patients with multifocal/upper tract urinary tract cancers.
We are currently collaborating in clinical trials of molecular-targeted therapies and dietary supplements that hold promise in the prevention of diagnosis, recurrence and/or progression of bladder cancer. Learn about our bladder cancer prevention clinical trials.
Kidney cancer is a disease that is treated primarily by surgery. At Lahey, we place emphasis on nephron-sparing surgery to help preserve renal function in patients who might otherwise suffer from kidney failure. We offer robotic as well as open renal surgery depending on the individual patient’s needs.
For patients who have advanced kidney cancer, Lahey is among the most highly experienced medical centers in the country in treating kidney cancer involving the vena cava.
Our current research efforts have focused on targeting specific antibodies to better diagnose renal cell carcinoma. Our research trial of G250 is an excellent example of this strategy, which we hope will benefit our patients in the near future by enabling better patient selection for surgical removal of kidney tumors.
While adrenal, testicular, penile and urethral cancers are less common, our highly experienced and skilled surgeons have cared for a great number of patients with these diseases. We bring a multidisciplinary approach to their care in partnership with the Sophia Gordon Cancer Center.
Lahey Hospital & Medical Center has one of the largest urethral cancer treatment programs in the U.S., due in large part to the work of Leonard Zinman, MD, in collaboration with colleagues in medical oncology and radiation oncology, in treating this challenging disease.